ITRM20060367A1 - Muteine del hngf usi terapeutici e composizioni farmaceutiche - Google Patents

Muteine del hngf usi terapeutici e composizioni farmaceutiche

Info

Publication number
ITRM20060367A1
ITRM20060367A1 ITRM20060367A ITRM20060367A1 IT RM20060367 A1 ITRM20060367 A1 IT RM20060367A1 IT RM20060367 A ITRM20060367 A IT RM20060367A IT RM20060367 A1 ITRM20060367 A1 IT RM20060367A1
Authority
IT
Italy
Prior art keywords
hngf
pharmaceutical compositions
therapeutic uses
mutein therapeutic
mutein
Prior art date
Application number
Other languages
English (en)
Inventor
Simona Capsoni
Antonino Cattaneo
Sonia Covaceuszach
Original Assignee
Lay Line Genomics Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lay Line Genomics Spa filed Critical Lay Line Genomics Spa
Priority to ITRM20060367 priority Critical patent/ITRM20060367A1/it
Priority to PCT/EP2007/057215 priority patent/WO2008006893A1/en
Publication of ITRM20060367A1 publication Critical patent/ITRM20060367A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITRM20060367 2006-07-13 2006-07-13 Muteine del hngf usi terapeutici e composizioni farmaceutiche ITRM20060367A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITRM20060367 ITRM20060367A1 (it) 2006-07-13 2006-07-13 Muteine del hngf usi terapeutici e composizioni farmaceutiche
PCT/EP2007/057215 WO2008006893A1 (en) 2006-07-13 2007-07-12 Muteins of hngf, therapeutic uses and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM20060367 ITRM20060367A1 (it) 2006-07-13 2006-07-13 Muteine del hngf usi terapeutici e composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
ITRM20060367A1 true ITRM20060367A1 (it) 2008-01-14

Family

ID=38508826

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM20060367 ITRM20060367A1 (it) 2006-07-13 2006-07-13 Muteine del hngf usi terapeutici e composizioni farmaceutiche

Country Status (2)

Country Link
IT (1) ITRM20060367A1 (it)
WO (1) WO2008006893A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20161364A1 (it) 2016-03-04 2017-09-04 Antonino Cattaneo Inibitore di tnf alpha astrocitario per l’uso nel trattamento di malattie neurologiche.
EP4292649A3 (en) * 2016-03-18 2024-02-21 Staidson(Beijing) Biopharmaceuticals Co., Ltd. Fusion protein comprising nerve growth factor and preparation method and use thereof
AR114110A1 (es) 2018-02-28 2020-07-22 Lilly Co Eli Anticuerpo anti-trka
EP3784691B1 (en) 2018-04-27 2026-03-25 Chiesi Farmaceutici S.p.A. Production of nerve growth factor (ngf) and of muteins thereof
WO2020058217A1 (en) * 2018-09-17 2020-03-26 Chiesi Farmaceutici S.P.A. Agent for treatment of dermatological disorders
PT4031117T (pt) * 2019-09-17 2024-10-25 Chiesi Farm Spa Mutante do ngf para utilização no tratamento ou prevenção de distúrbios oftálmicos
JP2023536229A (ja) * 2020-07-27 2023-08-24 ヒューマン セル カンパニー Ｎｇｆバリアント、産生、組成物、及び治療的使用
EP4039269A1 (en) * 2021-02-05 2022-08-10 Dompe' Farmaceutici S.P.A. Ngf isoform for use in the treatment of ocular pathologies
DK4313114T3 (da) 2021-03-25 2025-10-20 Chiesi Farm Spa Kombineret behandling af hjerneskade
CN120500725A (zh) * 2022-12-28 2025-08-15 舒泰神（北京）生物制药股份有限公司 一种筛选和/或鉴定ngf中的可突变位点的方法及其筛选和/或鉴定ngf突变体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365373B2 (en) * 1997-04-25 2002-04-02 Genentech, Inc. Nucleic acids encoding NGF variants
WO1998049308A1 (en) * 1997-04-25 1998-11-05 Genentech, Inc. Ngf variants
EP1689865A2 (en) * 2003-10-23 2006-08-16 Monika Holmberg A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto

Also Published As

Publication number Publication date
WO2008006893A1 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
EP1962961A4 (en) HALF-BODY: THERAPEUTIC AGENTS ACTIVATED BY DIMÉRIZATION
BRPI0923283A2 (pt) conjugados terapêuticos de peptídeo e usos dos mesmos
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK1959991T3 (da) Terapeutisk vaccine
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
BRPI0820381A2 (pt) Formulações farmacêuticas
EP2017280A4 (en) METALLOCENE COMPLEX AND POLYMERIZATION CATALYST COMPOSITION CONTAINING THE SAME
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
BRPI0511900A (pt) composições farmacêuticas
BRPI1009324A2 (pt) compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
ATE542815T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
BRPI0813000A2 (pt) Composições terapêuticas e uso das mesmas
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
DK1884242T3 (da) Farmaceutisk sammensætning omfattende lurasidon
CR10619A (es) Mimeticuerpos de peptido-1 similar a glucagon de humano, composiciones, metodos y usos
ATE493119T1 (de) Pharmazeutische zusammensetzung
DK2035369T3 (da) Terapeutiske
BRPI0921947A2 (pt) formulações de proteína terapêutica
EP2185112A4 (en) Stabilized therapeutic compositions and formulations
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
ATE530546T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
EP2341047A4 (en) CYCLOHEXANE DERIVATIVE AND ITS PHARMACEUTICAL USE
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
BRPI0913297A2 (pt) composição, farmacêutica, uso de uma composição, e, kit terapêutico.